Literature DB >> 18671962

Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts.

Yen-Ling Chen1, Ju-Chi Liu, Shih-Hurng Loh, Cheng-Hsien Chen, Chuang-Ye Hong, Jin-Jer Chen, Tzu-Hurng Cheng.   

Abstract

Urotensin II, a cyclic dodecapeptide, has recently been demonstrated to play an important role in cardiac remodeling and fibrosis. Cardiac fibroblast is the cell type known to proliferate during cardiac fibrosis and to produce the excess matrix proteins characteristic of cardiac remodeling. However, the effect of urotensin II on cardiac fibroblast proliferation and the intracellular mechanisms remain to be clarified. Cultured neonatal rat cardiac fibroblasts were stimulated with urotensin II, cell proliferation and the reactive oxygen species generation were examined. We also examined the effects of antioxidant pretreatment on urotensin II-induced cell proliferation, extracellular signal-regulated kinase phosphorylation, and the tyrosine phosphorylation of epidermal growth factor receptor, to elucidate the redox-sensitive pathway in urotensin II-induced cell proliferation. Urotensin II-increased cell proliferation and intracellular reactive oxygen species levels which were inhibited by antioxidants N-acetylcysteine, and the flavin inhibitor diphenyleneiodonium. Urotensin II potently activated the tyrosine phosphorylation of epidermal growth factor receptors and extracellular signal-regulated kinase. Pretreatment of cells with U0126, an inhibitor of the upstream activator of mitogen-activated protein kinase kinase, or with AG1478, a selective epidermal growth factor receptor kinase inhibitor, reduced the urotensin II-increased extracellular signal-regulated kinase phosphorylation. Antioxidants, U0126, and AG1478, all significantly inhibited urotensin II-increased cell proliferation in cardiac fibroblasts. Our data suggest that the redox-sensitive intracellular signaling pathway plays a role in urotensin II-induced proliferation in rat cardiac fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671962     DOI: 10.1016/j.ejphar.2008.07.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes.

Authors:  Hong-jye HONG; Ju-chi LIU; Tzu-hurng CHENG; Paul CHAN
Journal:  Acta Pharmacol Sin       Date:  2010-11-22       Impact factor: 6.150

Review 2.  Cardiac GPCR-Mediated EGFR Transactivation: Impact and Therapeutic Implications.

Authors:  Laurel A Grisanti; Shuchi Guo; Douglas G Tilley
Journal:  J Cardiovasc Pharmacol       Date:  2017-07       Impact factor: 3.105

3.  Desensitisation of native and recombinant human urotensin-II receptors.

Authors:  Madura S Batuwangala; Girolamo Calo; Remo Guerrini; Leong L Ng; John McDonald; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-08-13       Impact factor: 3.000

4.  Urotensin II inhibits skeletal muscle glucose transport signaling pathways via the NADPH oxidase pathway.

Authors:  Hong-Xia Wang; Xin-Rui Wu; Hui Yang; Chun-Lin Yin; Li-Jin Shi; Xue-Jiang Wang
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

5.  Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway.

Authors:  Hui Gong; Zhidan Chen; Xiaoyi Zhang; Yang Li; Jie Zhang; Ying Chen; Yingjiong Ding; Guoping Zhang; Chunjie Yang; Yichun Zhu; Yunzeng Zou
Journal:  Int J Mol Sci       Date:  2015-06-03       Impact factor: 5.923

6.  Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signalling.

Authors:  Zhidan Chen; Jiahong Xu; Yong Ye; Yang Li; Hui Gong; Guoping Zhang; Jian Wu; Jianguo Jia; Ming Liu; Ying Chen; Chunjie Yang; Yu Tang; Yichun Zhu; Junbo Ge; Yunzeng Zou
Journal:  J Cell Mol Med       Date:  2014-01-22       Impact factor: 5.310

7.  A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway.

Authors:  Tae-Ho Kim; Dong Gil Lee; Young-Ae Kim; Byung Ho Lee; Kyu Yang Yi; Yi-Sook Jung
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

Review 8.  The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.

Authors:  Hélène Castel; Laurence Desrues; Jane-Eileen Joubert; Marie-Christine Tonon; Laurent Prézeau; Marie Chabbert; Fabrice Morin; Pierrick Gandolfo
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-25       Impact factor: 5.555

9.  Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat.

Authors:  Heather J Eyre; Thomas Speight; Jocelyn D Glazier; David M Smith; Nick Ashton
Journal:  Exp Physiol       Date:  2019-01-15       Impact factor: 2.969

10.  Urotensin II induces interleukin 8 expression in human umbilical vein endothelial cells.

Authors:  Chung-Yi Lee; Yi-Tin Tsai; Shih-Hurng Loh; Ju-Chi Liu; Tso-Hsiao Chen; Hung-Hsing Chao; Tzu-Hurng Cheng; Jin-Jer Chen
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.